Evaxion - ROE 2020-2025 | EVAX

Current and historical return on equity (ROE) values for Evaxion - (EVAX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Evaxion - ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-03-31 $-0.02B $0.01B -457.14%
2024-09-30 $-0.02B $0.00B -316.67%
2024-06-30 $-0.02B $0.00B -184.00%
2023-06-30 $-0.03B $0.00B -123.46%
2022-06-30 $-0.02B $0.02B -101.05%
2022-03-31 $-0.03B $0.03B -107.22%
2021-12-31 $-0.02B $0.03B -96.97%
2021-09-30 $-0.02B $0.02B -108.11%
2021-06-30 $-0.02B $0.02B -133.33%
2021-03-31 $-0.02B $0.03B -182.86%
2020-12-31 $-0.02B $0.01B -857.14%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.004B $0.003B
Evaxion A/S is a clinical-stage TechBio company specializing in developing AI-Immunology(TM) powered vaccines. Evaxion A/S, formerly known as Evaxion Biotech A/S, is based in COPENHAGEN, Denmark.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.172B 59.16
Hims & Hers Health (HIMS) United States $12.418B 139.02
Tempus AI (TEM) United States $12.340B 0.00
IRhythm Technologies (IRTC) United States $4.592B 0.00
Inspire Medical Systems (INSP) United States $3.751B 59.77
Privia Health (PRVA) United States $2.761B 190.75
Hinge Health (HNGE) United States $2.719B 0.00
Enovis (ENOV) United States $1.822B 10.27
Schrodinger (SDGR) United States $1.572B 0.00
Phreesia (PHR) United States $1.547B 0.00
Clover Health Investments (CLOV) United States $1.468B 0.00
Azenta (AZTA) United States $1.401B 65.30
Omnicell (OMCL) United States $1.370B 24.15
10x Genomics (TXG) United States $1.282B 0.00
Fulgent Genetics (FLGT) United States $0.630B 0.00
Claritev (CTEV) United States $0.610B 0.00
Butterfly Network (BFLY) United States $0.569B 0.00
Veradigm (MDRX) United States $0.487B 0.00
Talkspace (TALK) United States $0.477B 140.50
Standard BioTools (LAB) United States $0.399B 0.00
Outset Medical (OM) United States $0.354B 0.00
TruBridge (TBRG) United States $0.347B 778.33
Health Catalyst (HCAT) United States $0.264B 0.00
Nyxoah SA (NYXH) Belgium $0.257B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.191B 0.00
KORU Medical Systems (KRMD) United States $0.149B 0.00
EUDA Health Holdings (EUDA) Singapore $0.138B 0.00
Pulmonx (LUNG) United States $0.122B 0.00
American Well (AMWL) United States $0.106B 0.00
MDxHealth SA (MDXH) Belgium $0.095B 0.00
CareCloud (CCLD) United States $0.088B 3.44
111 (YI) China $0.070B 0.00
HeartBeam (BEAT) United States $0.051B 0.00
P3 Health Partners (PIII) United States $0.048B 0.00
Zepp Health (ZEPP) Netherlands $0.033B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.032B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Precipio (PRPO) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.001B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00